REMY BIOSCIENCES BIODERMAL TECHNOLOGY
Live / Applied — Opposition pending (as of 21 Feb 2025)
What this means for you
Not registered yet, but its 22 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97603139
- Mark type
- Design + words
- Filed
- 22 Sept 2022
- Published for opposition
- 27 Aug 2024
- Attorney of record
- ARDELLE ST. GEORGE
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions
Owner
- REMY Biosciences, Inc., Newport Coast, CA, US
- REMY Biosciences, Inc., Newport Coast, CA, US
Prior registrations
Prosecution history
- 23 Feb 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 21 Feb 2025 — OPPOSITION INSTITUTED NO. 999999
- 25 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jan 2024 — NON-FINAL ACTION E-MAILED
- 22 Jan 2024 — NON-FINAL ACTION WRITTEN
- 21 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE